Education
About Us
Working with TipRanks
Follow Us
Eyepoint Pharma (DE:PV3B)
:PV3B
RESEARCH TOOLSreports
EyePoint Pharmaceuticals (PV3B) Ownership Overview
13.16% Insiders
19.18%
Mutual Funds
0.23% Other Institutional Investors
10.52% ETFs
56.91% Public Companies and
Individual Investors
The ownership structure of EyePoint Pharmaceuticals (DE:PV3B) stock is a mix of institutional, retail, and individual investors. Approximately 29.93% of the company’s stock is owned by Institutional Investors, 13.16% is owned by Insiders, and 56.91% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Aug 21, 2024 | Wendy Dicicco Interim Cfo | xxxxxxxxxxxxx | $19997 |
| Aug 21, 2024 | Goran Ando Director | xxxxxxxxxxxxx | $39750 |
| Aug 21, 2024 | Karen Zaderej Director | xxxxxxxxxxxxx | $99750 |
| Aug 20, 2024 | Nancy Lurker Director | xxxxxxxxxxxxx | $25003 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $3737843 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $11452691 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $23704544 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,325,000 | Insider | 12.11% | 46,736,550 | |
| 3,649,475 | Institution | 5.31% | 20,488,153 | |
| 3,620,334 | Institution | 5.27% | 20,324,555 | |
| 3,181,818 | Institution | 4.63% | 17,862,726 | |
| 3,075,254 | Institution | 4.47% | 17,264,476 | |
| 2,866,887 | Institution | 4.17% | 16,094,704 | |
| 2,216,797 | Institution | 3.23% | 12,445,098 | |
| 1,537,274 | Institution | 2.24% | 8,630,256 | |
| 1,149,657 | Institution | 1.67% | 6,454,174 | |
| 877,790 | Institution | 1.28% | 4,927,913 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,649,475 | Institution | 5.31% | 20,488,153 | |
| 3,075,254 | Institution | 4.47% | 17,264,476 | |
| 2,216,797 | Institution | 3.23% | 12,445,098 | |
| 1,149,657 | Institution | 1.67% | 6,454,174 | |
| 573,347 | Institution | 0.83% | 3,218,770 | |
| 532,149 | Institution | 0.77% | 2,987,484 | |
| 366,688 | Institution | 0.53% | 2,058,586 | |
| 280,319 | Institution | 0.41% | 1,573,711 | |
| 167,085 | Institution | 0.24% | 938,015 | |
| 150,427 | Institution | 0.22% | 844,497 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Eyepoint Pharma (DE:PV3B)?
According to the latest TipRanks data, approximately 0.23% of the company's stock is held by institutional investors, 13.16% is held by insiders, and 56.91% is held by retail investors.
What percentage of Eyepoint Pharma (DE:PV3B) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.23% of Eyepoint Pharma (DE:PV3B) stock is held by institutional investors.
What percentage of Eyepoint Pharma (DE:PV3B) stock is held by retail investors?
According to the latest TipRanks data, approximately 56.91% of Eyepoint Pharma (DE:PV3B) stock is held by retail investors.
Who owns the most shares of Eyepoint Pharma (DE:PV3B)?
Cormorant Asset Management, LLC owns the most shares of Eyepoint Pharma (DE:PV3B).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.